Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 4/20 | 1.00 |
| ▸ | NR4A2 | P43354 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 0.72 |
| ▸ | LMNA | P02545 | 2/20 | 0.72 |
| ▸ | HPGD | P15428 | 2/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.72 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.72 |
| ▸ | POLB | P06746 | 1/20 | 0.72 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.72 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.72 |
| ▸ | PTGER4 | P35408 | 5/20 | 0.64 |
| ▸ | PTGER2 | P43116 | 3/20 | 0.64 |
| ▸ | PTGIR | P43119 | 3/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.64 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Prostaglandin A1 SCHEMBL6417551 | 1.00 | TRPA1 (1.00) | TRPA1NR4A2MEN1LMNAHPGD | |
| Prostaglandin A1 SCHEMBL11650631 | 1.00 | TRPA1 (1.00) | TRPA1NR4A2MEN1LMNAHPGD | |
| Prostaglandin A1 SCHEMBL17914205 | 1.00 | TRPA1 (1.00) | TRPA1NR4A2MEN1LMNAHPGD | |
| Prostaglandin A1 SCHEMBL8347686 | 1.00 | TRPA1 (1.00) | TRPA1NR4A2MEN1LMNAHPGD | |
| Prostaglandin A1 SCHEMBL3366007 | 1.00 | TRPA1 (1.00) | TRPA1NR4A2MEN1LMNAHPGD | |
| Prostaglandin A1 SCHEMBL14577651 | 1.00 | TRPA1 (1.00) | TRPA1NR4A2MEN1LMNAHPGD | |
| Prostaglandin A1 SCHEMBL23717317 | 1.00 | TRPA1 (1.00) | TRPA1NR4A2MEN1LMNAHPGD | |
| Prostaglandin A1 SCHEMBL13649323 | 1.00 | TRPA1 (1.00) | TRPA1NR4A2MEN1LMNAHPGD | |
| Prostaglandin A1 SCHEMBL22425783 | 1.00 | TRPA1 (1.00) | TRPA1NR4A2MEN1LMNAHPGD | |
| Prostaglandin A1 SCHEMBL8347690 | 1.00 | TRPA1 (1.00) | TRPA1NR4A2MEN1LMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 536 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119944436-B | Multi-step ridge type laser structure and preparation method thereof | 四川布鲁镭光科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-122038348-A | Genome editing system for corynebacterium glutamicum | 中国科学院分子植物科学卓越创新中心 | 2026-05-15 | — | — | CN | claimed |
| US-12605345-B2 | Transdermal drug delivery system | BioPhysics Pharma, Inc. (US) | 2026-04-21 | — | — | US | claimed |
| US-20250268841-A1 | Trans-Epithelial Membrane Drug Delivery System | Masiz, John J. (US) | 2025-08-28 | — | — | US | claimed |
| CN-119944436-A | Multi-step ridge type laser structure and preparation method thereof | 四川布鲁镭光科技有限公司 | 2025-05-06 | — | — | CN | claimed |
| US-20250120907-A1 | Transmucosal Drug Delivery System | Masiz, John J. (US) | 2025-04-17 | — | — | US | claimed |
| CN-119788011-A | Gain adjusting circuit of programmable gain amplifier and adjusting method thereof | 慷智集成电路(上海)有限公司 | 2025-04-08 | — | — | CN | claimed |
| US-12246098-B2 | Trans-epithelial membrane drug delivery system | BioPhysics Pharma, Inc. (US) | 2025-03-11 | — | — | US | claimed |
| CN-119584743-A | Micro LED chip and manufacturing method thereof | 北京字跳网络技术有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-119362427-A | Forced power oscillation disturbance source positioning method based on KDE transfer entropy causal analysis | 东北电力大学 | 2025-01-24 | — | — | CN | claimed |
| CN-113992171-B | Receiver and automatic gain control method thereof | 华南理工大学 | 2022-06-24 | — | — | CN | claimed |
| US-20220175701-A1 | TREATMENT OF MAJOR DEPRESSIVE DISORDER AND SUICIDAL IDEATIONS THROUGH STIMULATION OF HIPPOCAMPAL NEUROGENESIS UTILIZING PLANT-BASED APPROACHES | THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (US) | 2022-06-09 | — | — | US | claimed |
| CN-110334458-B | Structural seismic capacity assessment method considering influence of initial damage state | 哈尔滨工业大学 | 2022-05-24 | — | — | CN | claimed |
| CN-114430276-A | Universal synchronous acquisition analog front end for piezoelectric signals and voltage reference circuit thereof | 哈尔滨理工大学 | 2022-05-03 | — | — | CN | claimed |
| CN-114300011-A | SRAM (static random Access memory) construction method, device, storage medium and intelligent equipment | 上海华力集成电路制造有限公司 | 2022-04-08 | — | — | CN | claimed |
| US-11279876-B2 | Phosphor and light-emitting device using same | DENKA COMPANY LIMITED (JP) | 2022-03-22 | — | — | US | claimed |
| CN-111658628-B | Application of GLI2 inhibitor and screening method of compound inhibiting GLI2 | 中国科学院动物研究所 | 2022-03-01 | — | — | CN | claimed |
| CN-113992171-A | Receiver and automatic gain control method thereof | 华南理工大学 | 2022-01-28 | — | — | CN | claimed |
| EP-0470251-B1 | LIQUID PROSTAGLANDIN COMPOSITION | GREEN CROSS CORP (JP) | 1996-02-07 | — | — | EP | claimed |
| EP-0470251-A1 | LIQUID PROSTAGLANDIN COMPOSITION | THE GREEN CROSS CORPORATION (JP) | 1992-02-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12605345-B2 | Transdermal drug delivery system | FABP2, VEGFA, CUTA | TRPA1 325/4885NR4A2 1088/4885MEN1 922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.